383 related articles for article (PubMed ID: 10866368)
1. Synthesis and evaluation of 9,9-dimethylxanthene tricyclics against trypanothione reductase, Trypanosoma brucei, Trypanosoma cruzi and Leishmania donovani.
Chibale K; Visser M; Yardley V; Croft SL; Fairlamb AH
Bioorg Med Chem Lett; 2000 Jun; 10(11):1147-50. PubMed ID: 10866368
[TBL] [Abstract][Full Text] [Related]
2. Phenothiazine inhibitors of trypanothione reductase as potential antitrypanosomal and antileishmanial drugs.
Chan C; Yin H; Garforth J; McKie JH; Jaouhari R; Speers P; Douglas KT; Rock PJ; Yardley V; Croft SL; Fairlamb AH
J Med Chem; 1998 Jan; 41(2):148-56. PubMed ID: 9457238
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and in vitro antikinetoplastid activity of polyamine-hydroxybenzotriazole conjugates.
Jagu E; Pomel S; Diez-Martinez A; Ramiandrasoa F; Krauth-Siegel RL; Pethe S; Blonski C; Labruère R; Loiseau PM
Bioorg Med Chem; 2017 Jan; 25(1):84-90. PubMed ID: 27793448
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of phenothiazine- and phenoxazine-derived chloroacetamides on Leishmania major growth and Trypanosoma brucei trypanothione reductase.
Marcu A; Schurigt U; Müller K; Moll H; Krauth-Siegel RL; Prinz H
Eur J Med Chem; 2016 Jan; 108():436-443. PubMed ID: 26708110
[TBL] [Abstract][Full Text] [Related]
5. Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents.
Cogo J; Cantizani J; Cotillo I; Sangi DP; Corrêa AG; Ueda-Nakamura T; Filho BPD; Martín JJ; Nakamura CV
Bioorg Med Chem; 2018 Aug; 26(14):4065-4072. PubMed ID: 30100019
[TBL] [Abstract][Full Text] [Related]
6. Structure-activity study on the in vitro antiprotozoal activity of glutathione derivatives.
D'Silva C; Daunes S
J Med Chem; 2000 May; 43(10):2072-8. PubMed ID: 10821719
[TBL] [Abstract][Full Text] [Related]
7. Use of an additional hydrophobic binding site, the Z site, in the rational drug design of a new class of stronger trypanothione reductase inhibitor, quaternary alkylammonium phenothiazines.
Khan MO; Austin SE; Chan C; Yin H; Marks D; Vaghjiani SN; Kendrick H; Yardley V; Croft SL; Douglas KT
J Med Chem; 2000 Aug; 43(16):3148-56. PubMed ID: 10956223
[TBL] [Abstract][Full Text] [Related]
8. Squalamine analogues as potential anti-trypanosomal and anti-leishmanial compounds.
Khabnadideh S; Tan CL; Croft SL; Kendrick H; Yardley V; Gilbert IH
Bioorg Med Chem Lett; 2000 Jun; 10(11):1237-9. PubMed ID: 10866389
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
[TBL] [Abstract][Full Text] [Related]
10. Design, synthesis and evaluation of 2,4-diaminoquinazolines as inhibitors of trypanosomal and leishmanial dihydrofolate reductase.
Khabnadideh S; Pez D; Musso A; Brun R; Pérez LM; González-Pacanowska D; Gilbert IH
Bioorg Med Chem; 2005 Apr; 13(7):2637-49. PubMed ID: 15755663
[TBL] [Abstract][Full Text] [Related]
11. Irreversible inactivation of trypanothione reductase by unsaturated Mannich bases: a divinyl ketone as key intermediate.
Lee B; Bauer H; Melchers J; Ruppert T; Rattray L; Yardley V; Davioud-Charvet E; Krauth-Siegel RL
J Med Chem; 2005 Nov; 48(23):7400-10. PubMed ID: 16279799
[TBL] [Abstract][Full Text] [Related]
12. Spiro-containing derivatives show antiparasitic activity against Trypanosoma brucei through inhibition of the trypanothione reductase enzyme.
Turcano L; Battista T; De Haro ET; Missineo A; Alli C; Paonessa G; Colotti G; Harper S; Fiorillo A; Ilari A; Bresciani A
PLoS Negl Trop Dis; 2020 May; 14(5):e0008339. PubMed ID: 32437349
[TBL] [Abstract][Full Text] [Related]
13. Parallel synthesis of a library of 1,4-naphthoquinones and automated screening of potential inhibitors of trypanothione reductase from Trypanosoma cruzi.
Salmon-Chemin L; Lemaire A; De Freitas S; Deprez B; Sergheraert C; Davioud-Charvet E
Bioorg Med Chem Lett; 2000 Apr; 10(7):631-5. PubMed ID: 10762041
[TBL] [Abstract][Full Text] [Related]
14. Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy.
Martin MB; Grimley JS; Lewis JC; Heath HT; Bailey BN; Kendrick H; Yardley V; Caldera A; Lira R; Urbina JA; Moreno SN; Docampo R; Croft SL; Oldfield E
J Med Chem; 2001 Mar; 44(6):909-16. PubMed ID: 11300872
[TBL] [Abstract][Full Text] [Related]
15. Binding to large enzyme pockets: small-molecule inhibitors of trypanothione reductase.
Persch E; Bryson S; Todoroff NK; Eberle C; Thelemann J; Dirdjaja N; Kaiser M; Weber M; Derbani H; Brun R; Schneider G; Pai EF; Krauth-Siegel RL; Diederich F
ChemMedChem; 2014 Aug; 9(8):1880-91. PubMed ID: 24788386
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of novel guttiferone A derivatives: in-vitro evaluation toward Plasmodium falciparum, Trypanosoma brucei and Leishmania donovani.
Fromentin Y; Gaboriaud-Kolar N; Lenta BN; Wansi JD; Buisson D; Mouray E; Grellier P; Loiseau PM; Lallemand MC; Michel S
Eur J Med Chem; 2013 Jul; 65():284-94. PubMed ID: 23727538
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and antiprotozoal activity of original porphyrin precursors and derivatives.
Abada Z; Cojean S; Pomel S; Ferrié L; Akagah B; Lormier AT; Loiseau PM; Figadère B
Eur J Med Chem; 2013 Sep; 67():158-65. PubMed ID: 23851117
[TBL] [Abstract][Full Text] [Related]
18. Synthesis, in-vitro antiprotozoal activity and molecular docking study of isothiocyanate derivatives.
Babanezhad Harikandei K; Salehi P; Ebrahimi SN; Bararjanian M; Kaiser M; Al-Harrasi A
Bioorg Med Chem; 2020 Jan; 28(1):115185. PubMed ID: 31784198
[TBL] [Abstract][Full Text] [Related]
19. Computational and Investigative Study of Flavonoids Active Against Typanosoma cruzi and Leishmania spp.
Ribeiro FF; Junior FJ; da Silva MS; Scotti MT; Scotti L
Nat Prod Commun; 2015 Jun; 10(6):917-20. PubMed ID: 26197515
[TBL] [Abstract][Full Text] [Related]
20. Potent and specific inhibitors of trypanothione reductase from Trypanosoma cruzi: bis(2-aminodiphenylsulfides) for fluorescent labeling studies.
Girault S; Davioud-Charvet TE; Maes L; Dubremetz JF; Debreu MA; Landry V; Sergheraert C
Bioorg Med Chem; 2001 Apr; 9(4):837-46. PubMed ID: 11354666
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
